MSD United Kingdom
UK affiliate of a global biopharmaceutical company conducting interdisciplinary early discovery across chemistry, pharmacology, neuroscience and immunology; sponsoring and operating clinical studies in the UK; and partnering with NHS organisations and academic centres on clinical pathway optimisation, service redesign and public‑health programmes. Examples include regional capacity and demand modelling for systemic anti‑cancer therapy (SACT), clinical pathway development for skin cancer, co‑design of local vaccine delivery models, deployment of digital patient engagement and pre‑assessment tools, pathology and MDT pathway optimisation, and laboratory sustainability initiatives.
Industries
N/A
Nr. of Employees
small (1-50)
MSD United Kingdom
Merck Sharp & Dohme (UK) Limited 120 Moorgate London EC2M 6UR
Products
Human medicines and vaccines
Research‑driven portfolio of prescription medicines and vaccines across multiple therapeutic areas for prevention and treatment of disease.
Veterinary medicines and services
Development, manufacture and marketing of veterinary products and services for farm and companion animals.
Educational reports, infographics and policy documents
Published resources including health‑economics infographics, policy consensus statements and case‑study reports to inform practice and policy.
Human medicines and vaccines
Research‑driven portfolio of prescription medicines and vaccines across multiple therapeutic areas for prevention and treatment of disease.
Veterinary medicines and services
Development, manufacture and marketing of veterinary products and services for farm and companion animals.
Educational reports, infographics and policy documents
Published resources including health‑economics infographics, policy consensus statements and case‑study reports to inform practice and policy.
Services
Design and execution of company‑sponsored clinical studies with site engagement, monitoring and safety oversight.
Provision of capacity‑modelling analyses, facilitated workshops, dashboards and follow‑up evaluation to inform trust and cancer‑alliance action plans for systemic anti‑cancer therapy delivery.
Project‑based pathway mapping, gap analysis, implementation support and measurement to optimise incidental skin cancer referral and treatment pathways. A regional example delivered updated referral processes and measured improvements in treatment performance metrics.
Pathway mapping, gap analysis and implementation support for histopathology and molecular testing to reduce turnaround times and enable appropriate in‑house testing.
Implementation and evaluation of virtual pre‑assessment pathways using mobile/web platforms to release clinical capacity and improve patient experience.
Co‑design and deployment of symptom‑checkers, self‑referral tools, healthbots and ePROM platforms to increase service uptake and capture patient experience data.
Design and execution of company‑sponsored clinical studies with site engagement, monitoring and safety oversight.
Provision of capacity‑modelling analyses, facilitated workshops, dashboards and follow‑up evaluation to inform trust and cancer‑alliance action plans for systemic anti‑cancer therapy delivery.
Project‑based pathway mapping, gap analysis, implementation support and measurement to optimise incidental skin cancer referral and treatment pathways. A regional example delivered updated referral processes and measured improvements in treatment performance metrics.
Pathway mapping, gap analysis and implementation support for histopathology and molecular testing to reduce turnaround times and enable appropriate in‑house testing.
Implementation and evaluation of virtual pre‑assessment pathways using mobile/web platforms to release clinical capacity and improve patient experience.
Co‑design and deployment of symptom‑checkers, self‑referral tools, healthbots and ePROM platforms to increase service uptake and capture patient experience data.
Expertise Areas
- Drug discovery and early‑stage translational research
- Structural biology and cellular imaging
- Clinical trial operations and sponsorship
- Clinical data integration and clinician dashboard deployment
Key Technologies
- Capacity and demand modelling tools for healthcare services
- Service performance dashboards and reporting
- Time‑and‑motion observational methods
- Virtual pre‑assessment and digital patient engagement platforms
News & Updates
Summary of regional projects delivering capacity and demand modelling, facilitated workshops and implementation support to optimise SACT delivery across multiple cancer alliances.
Project summary describing pathway mapping, gap analysis, implementation of an updated referral pathway for incidental melanoma, and measured improvements in 31‑day treatment performance and decision‑to‑treat intervals.
Six‑month co‑design pilot to identify local solutions to improve Flu and Covid vaccination accessibility and uptake, using stakeholder engagement and data review to inform deployment options.
Recognition for producing public‑facing health information that meets an accredited quality standard for clarity and accessibility.
Sustainable‑science certification awarded to laboratory sites following assessment of equipment, practices and resource use.
Summary of regional projects delivering capacity and demand modelling, facilitated workshops and implementation support to optimise SACT delivery across multiple cancer alliances.
Project summary describing pathway mapping, gap analysis, implementation of an updated referral pathway for incidental melanoma, and measured improvements in 31‑day treatment performance and decision‑to‑treat intervals.
Six‑month co‑design pilot to identify local solutions to improve Flu and Covid vaccination accessibility and uptake, using stakeholder engagement and data review to inform deployment options.
Recognition for producing public‑facing health information that meets an accredited quality standard for clarity and accessibility.
Sustainable‑science certification awarded to laboratory sites following assessment of equipment, practices and resource use.